Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing
暂无分享,去创建一个
J. Lancaster | C. Adami | A. Gutin | J. Garber | M. Robson | A. Kurian | S. Domchek | J. Lanchbury | J. Weitzel | T. Judkins | S. Wagner | E. Rosenthal | Elisha Hughes | K. Dalton | D. Grear | W. Hedegard | Stephanie Meek | Shannon Gallagher | B. Roa | Placede T Tshiaba | S. Gallagher | P. Tshiaba
[1] James Y. Dai,et al. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk , 2020, Journal of the National Cancer Institute.
[2] Jennifer L. Caswell-Jin,et al. Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer. , 2020, JAMA.
[3] H. Brenner,et al. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer. , 2019, JAMA oncology.
[4] Gretchen L. Gierach,et al. Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines. , 2019, JAMA oncology.
[5] S. Astley,et al. A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density , 2019, International journal of cancer.
[6] A. Hollestelle,et al. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families , 2019, Journal of Medical Genetics.
[7] X. Castells,et al. A systematic review and quality assessment of individualised breast cancer risk prediction models , 2019, British Journal of Cancer.
[8] Gord Glendon,et al. 10-year performance of four models of breast cancer risk: a validation study. , 2019, The Lancet. Oncology.
[9] M. García-Closas,et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.
[10] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[11] W. Willett,et al. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case–control study , 2018, PLoS medicine.
[12] C. Turnbull,et al. Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group , 2018, Journal of Medical Genetics.
[13] S. Astley,et al. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction , 2018, JAMA oncology.
[14] Alexander Gutin,et al. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. , 2017, JCO precision oncology.
[15] Jack Cuzick,et al. Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Cuzick,et al. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case–control study , 2016, Journal of Medical Genetics.
[17] Nilanjan Chatterjee,et al. iCARE: R package to build, validate and apply absolute risk models , 2016, bioRxiv.
[18] A. Whittemore,et al. Genetic modifiers of CHEK2*1100delC associated breast cancer risk , 2016, Genetics in Medicine.
[19] Mark E. Robson,et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations , 2016, Nature Reviews Clinical Oncology.
[20] S. Cummings,et al. Breast cancer risk prediction using a clinical risk model and polygenic risk score , 2016, Breast Cancer Research and Treatment.
[21] Sofia Khan,et al. Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families , 2016, Breast Cancer Research and Treatment.
[22] Rochelle Fu,et al. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation , 2016, Annals of Internal Medicine.
[23] G. Giles,et al. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[24] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[25] Satish Bhatnagar,et al. T E C H N I C a L a D V a N C E Open Access , 2022 .
[26] J. Murabito,et al. Genome-wide association studies of age at menarche and age at natural menopause , 2014, Molecular and Cellular Endocrinology.
[27] Erik Ingelsson,et al. Genome-wide association studies of obesity and metabolic syndrome , 2014, Molecular and Cellular Endocrinology.
[28] Anne Marie McCarthy,et al. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women , 2013, Breast Cancer Research and Treatment.
[29] David A. Hinds,et al. Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.
[30] M. Thun,et al. Performance of Common Genetic Variants in Breast-cancer Risk Models , 2022 .
[31] M. Gail. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. , 2009, Journal of the National Cancer Institute.
[32] J. Hopper,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.
[33] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[34] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.
[35] A Howell,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[36] J Benichou,et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.
[37] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[38] Peter Dalgaard,et al. R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .